Addressing high flow overuse in bronchiolitis - Successes and future directions.

Autor: Ford T; Emory University School of Medicine, Pediatric Hospital Medicine, Department of Pediatrics, Children's Healthcare of Atlanta, 1405 Clifton Road, Atlanta, GA 30322, United States., Lane J; Oregon Health and Science University, Pediatric Hospital Medicine, Department of Pediatrics, Oregon Health & Science University, 707 SW Gaines Street, mail code CDRCP, Portland, OR 97239, United States., Noelck M; Oregon Health and Science University, Pediatric Hospital Medicine, Department of Pediatrics, Oregon Health & Science University, 707 SW Gaines Street, mail code CDRCP, Portland, OR 97239, United States., Byrd C; Emory University School of Medicine, Pediatric Hospital Medicine, Department of Pediatrics, Children's Healthcare of Atlanta, 1405 Clifton Road, Atlanta, GA 30322, United States. Electronic address: ccharva@emory.edu.
Jazyk: angličtina
Zdroj: Paediatric respiratory reviews [Paediatr Respir Rev] 2024 Dec; Vol. 52, pp. 14-17. Date of Electronic Publication: 2024 Jun 05.
DOI: 10.1016/j.prrv.2024.06.002
Abstrakt: The use of high flow nasal cannula (HFNC) in the treatment of bronchiolitis has markedly increased in the last decade, yet randomized controlled trials have reported little clinical benefit with early, routine use. This article provides a concise overview of the current status of HFNC therapy, discusses successful de-implementation strategies to curtail HFNC overuse, and explores future bronchiolitis and HFNC quality improvement and research considerations.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2024 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: